US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

DNAY

Codex DNA (DNAY)

Codex DNA Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:DNAY

1 2 3 4 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/06/21	05 : 11	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	NASDAQ:DNAY	Codex DNA Inc
2023/06/16	05 : 19	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:DNAY	Codex DNA Inc
2023/06/10	05 : 48	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:DNAY	Codex DNA Inc
2023/06/09	07 : 12	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DNAY	Codex DNA Inc
2023/06/09	07 : 10	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:DNAY	Codex DNA Inc
2023/06/08	05 : 13	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DNAY	Codex DNA Inc
2023/05/25	05 : 35	Edgar (US Regulatory)	Annual Report to Security Holders (ars)	NASDAQ:DNAY	Codex DNA Inc
2023/05/18	05 : 08	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:DNAY	Codex DNA Inc
2023/05/18	05 : 03	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:DNAY	Codex DNA Inc
2023/05/06	07 : 23	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:DNAY	Codex DNA Inc
2023/05/03	05 : 08	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:DNAY	Codex DNA Inc
2023/04/19	19 : 02	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:DNAY	Codex DNA Inc
2023/03/25	05 : 02	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:DNAY	Codex DNA Inc
2023/03/22	19 : 32	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:DNAY	Codex DNA Inc
2023/03/22	05 : 16	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:DNAY	Codex DNA Inc
2023/02/15	03 : 10	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:DNAY	Codex DNA Inc
2023/01/28	06 : 19	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:DNAY	Codex DNA Inc
2023/01/11	07 : 02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:DNAY	Codex DNA Inc
2023/01/09	23 : 00	GlobeNewswire Inc.	Telesis Bio Pre-Announces Preliminary Fourth Quarter Financial Results	NASDAQ:DNAY	Codex DNA Inc
2022/11/09	20 : 08	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:DNAY	Codex DNA Inc
2022/11/09	06 : 10	GlobeNewswire Inc.	Telesis Bio Inc. Reports Third Quarter 2022 Financial Results	NASDAQ:DNAY	Codex DNA Inc
2022/11/08	20 : 04	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:DNAY	Codex DNA Inc
2022/11/03	05 : 19	GlobeNewswire Inc.	Telesis Bio to Report Third Quarter 2022 Financial Results and Provide a Corporate Update on November 8	NASDAQ:DNAY	Codex DNA Inc
2022/10/29	06 : 17	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:DNAY	Codex DNA Inc
2022/10/19	22 : 00	GlobeNewswire Inc.	Telesis Bio and Cellibre Announce Collaboration to Optimize Development of Future BioXp® DBC instrument	NASDAQ:DNAY	Codex DNA Inc
2022/10/12	22 : 00	GlobeNewswire Inc.	Codex DNA Announces Plan to Change Corporate Name to Telesis Bio	NASDAQ:DNAY	Codex DNA Inc
2022/10/04	22 : 00	GlobeNewswire Inc.	Codex DNA Expands Application of Proprietary Error Correction Technology	NASDAQ:DNAY	Codex DNA Inc
2022/09/26	20 : 00	GlobeNewswire Inc.	Codex DNA Showcases Next Generation Automated Synthetic Biology Workstation at World of Technology & Science in Utrecht, Netherlands	NASDAQ:DNAY	Codex DNA Inc
2022/09/19	20 : 00	GlobeNewswire Inc.	Codex DNA Debuts Next-Generation Automated Synthetic Biology Workstation	NASDAQ:DNAY	Codex DNA Inc
2022/08/22	19 : 05	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:DNAY	Codex DNA Inc

Showing the most relevant articles for your search:NASDAQ:DNAY

1 2 3 4 次へ >>

Energy Select Sector SPDR

Verizon Communications

Invesco QQQ Trust Series 1

JP Morgan Chase

Health Care Select Sector

Deutsche Telekom (QX)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約